TreeFrog Therapeutics
@treefrogtx
Followers
891
Following
1K
Media
223
Statuses
588
TreeFrog Therapeutics is a French-based biotech aiming to unlock access to #iPS #StemCell derived #CellTherapies for millions of patients. #CellTherapyForAll
Pessac, France
Joined March 2018
CP: #ThérapiesCellulaires: @treefrogtx passe à la fabrication industrielle grâce à une nouvelle machine aux normes BPF! Next : Transfert #CDMO en 2023. Essai clinique #Parkinson en 2024. Et 3 nouveaux encapsulateurs livrés en 2023 pour accélérer! #FT120
https://t.co/xorC4E2X52
2
1
8
"Scaling-up iPSC-based cell therapies: towards clinical grade processes with biomimetic C-Stem technology" Next Wednesday, don't miss Senior Application Scientist Odette Becheau oral presentation at the BELSACT Scientific Meeting in #Leuven. Do not hesitate to connect with her!
1
0
3
Our #CSO Maxime Feyeux gives a snapshot of #pluripotent #stemcell #differentiation with the C-Stem™ platform. You can check the other videos answering frequently asked questions about C-Stem™ for #iPS #expansion & #differentiation here:
We get this question a lot: Can you #differentiate #pluripotent #stemcells into any cell type in C-Stem™-generated alginate capsules? Here a quick answer. Link to our latest paper on #iPSC expansion, with some trilineage data (Fig. 3): https://t.co/wvB6NR6BzE
1
0
6
After the largest, longest ph 3 of any CAR-T #celltherapy, @KitePharma's Yescarta is the 1st treatment in nearly 30 yrs to show stat significant improvement in OS for initial treatment of relapsed/refractory large B-cell lymphoma versus historical SOC.
europeanpharmaceuticalreview.com
Yescarta® is the first treatment in over 30 years to show significant improvement in overall survival in R/R lymphoma versus historical SOC.
0
5
11
@treefrogtx will be in #California next week ! Immuno-oncology Scientist Hélène CABANAS will attend the #InnateKillerSummit 2023, from March 28th to 30th. Do not hesitate to connect with her! #celltherapyforall
0
0
1
@treefrogtx' co-founder and CSO Maxime Feyeux will give a talk on scale-up at @JSRM_Official meeting (March 24). Do not hesitate to connect with him on-site or during his 2-week trip through Tokyo, Kyoto, Kobe, Osaka and Fukuoka, from March 20th to April 1st. #celltherapyforall
0
0
1
The @treefrogtx alginate encapsulation system efficiency could be due to its ability to recapitulate in capsulo a 3D lumenized colony that morphologically resembles an epiblast rosette, and which has higher cell viability than 2D colonies. https://t.co/5npPuffGw9
0
3
6
Following our recent paper describing #hiPSC #ScaleUp in #10L #bioreactors, our CSO highlights how the C-Stem™ platform can impact the manufacturing of stem cell-derived therapies. More videos answering frequently asked questions about C-Stem™ :
What does the C-Stem™ platform bring to the #CellTherapy field? For once I am the one answering questions in this short video about our latest paper in #Biomaterials. 5 other videos addressing FAQS about C-Stem are online: https://t.co/dRAV0bo6Yw
0
3
2
New publication demonstrating almost 300-fold #hiPSC expansion in 10L #bioreactors within 1 week with #CStem biomimetic platform with high reproducibility & preservation of cell quality. https://t.co/Nzou4V9t45
@ISSCR @ISCTglobal @FSSCR_officiel @JSRM_Official @ESGCT @alliancerm
1
8
16
Happening live TOMORROW! ⚠️ This is your last chance to sign for this webinar on #pluripotent stem cells with Dr. Maxime Feyeux (@FeyeuxMaxime):
What can the human body 🧍 teach us about how to scale up high-quality #pluripotent stem cells (PSCs)? Join us for a live webinar on March 7, with Dr. Maxime Feyeux (@FeyeuxMaxime), co-founder of TreeFrog Therapeutics (@treefrogtx), to find out.
0
3
3
Releasing a pretty exhaustive list of cell therapy trials based on iPS & ES cells! Access for free and share! https://t.co/YGCVYNzK5w
@pknoepfler @alliancerm @ISSCR @ISCTglobal @STEMCELLTech @nyscf @JSRM_Official @LINKJ20160324 @IPSCtherapies @ESC_iPSC_News
0
1
8
What can the human body 🧍 teach us about how to scale up high-quality #pluripotent stem cells (PSCs)? Join us for a live webinar on March 7, with Dr. Maxime Feyeux (@FeyeuxMaxime), co-founder of TreeFrog Therapeutics (@treefrogtx), to find out.
0
3
5
3/6 Gaia Biomedicine & @treefrogtx announce collaboration for the expansion of allogeneic NK-like cells against solid tumors.
1
2
5
Releasing a #whitepaper on the lumenized rosette - the 3D conformation adopted by human #PluripotentStemCells in vivo ! Properties / PSC growth & quality / comparison with 2D/aggregates / Biomimetic PSC culture in large-scale bioreactors Download : https://t.co/s8g08vzqwq
0
2
8
It's great to see some of our #startups in the new #FT120 & #Next40 rankings! Kudos to @LeCollectionist @treefrogtx @Skelloapp @Ledger @applydia @360Learning 🤩👏
0
4
17
TreeFrog dans le #FT120 ! Quelle trajectoire ? Quels jalons à venir ? Quel impact en France ? 2 min avec Jean-Luc TREILLOU, co-fondateur de @treefrogtx. Bienvenue aux nouveaux entrants dans le FrenchTech120, et un grand merci à @LaFrenchTech !
0
4
12
What to find on our new scientific blog ? #1 Exclusive & free resources: a list of #CellTherapy #trials based on #Pluripotent #StemCells, a white paper on the lumenized rosette – the specific 3D conformation adopted by hPSCs in vivo, interviews... https://t.co/OAM0sAKkfy
0
0
0
Press Release : Clinical-stage Japanese biotech Gaia Biomedicine & TreeFrog Therapeutics announce collaboration for the expansion of allogeneic NK-like cells against solid tumors. Full press release: https://t.co/hWtnqPHuPI
1
0
4
@treefrogtx team will start 2023 in #SanFrancisco ! Frédéric Desdouits and Kévin Alessandri will attend the J.P. Morgan 41st annual Healthcare Meeting from January 9th to 12th 2023. Feel free to reach out to schedule a meeting. #JPMorgan #celltherapyforall
0
0
1
Meet us next week at iPSC-Derived Cell Therapies Summit, from December 6th to 7th in Boston ! Feel free to connect with our Boston team, CTO Kévin Alessandri and BD Officer Anthony Renodon, based in @LabCentral (@MassBio). #Boston #celltherapyforall
0
0
0